GENTIAN DIAGNOSTICS ASA: årsregnskap 2025 vs 2024
Grew 139863% on revenue, weaker earnings
approved 2026-05-05; registry 2026-07-08; journal 2026 542125
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for GENTIAN DIAGNOSTICS ASA. Revenue 1 604 NOK → 2.25m NOK (+139862.6%). Net result -3.41m NOK → -10.52m NOK. Equity 4.25bn NOK → 4.24bn NOK.
On the constructive side: revenue rose; cash rose; owners injected capital. Pressures included: operating result weakened; net result weakened; equity eroded.
Also worth watching: book investments changed. All figures are taken from the published annual accounts for GENTIAN DIAGNOSTICS ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 1 604 NOK to 2.25m NOK (+139862.6% YoY). Calculated
-
↑
Cash rose
Bank deposits 67.25m NOK → 68.59m NOK (+2.0% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 309.11m NOK → 318.23m NOK (+9.12m NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result -10.17m NOK → -14.04m NOK (op. margin -633940.3% → -625.5%). Calculated
-
↓
Net result weakened
Net result -3.41m NOK → -10.52m NOK (net margin -212424.3% → -468.7%). Calculated
-
↓
Equity eroded
Book equity 4.25bn NOK → 4.24bn NOK (equity ratio 1632.9% → 1668.5%). Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 186.28m NOK → 181.94m NOK. Reported fact